Variable | N (%) Median (Range) |
Gender |
|
Female | 78 (57.4%) |
Male | 58 (42.6%) |
Age | 38 (38% - 50%) |
Marital Status |
|
Married/Living in | 93 (68.3%) |
Single | 10 (7.3%) |
Divorced/Separated | 8 (5.8%) |
Widowed | 25 (18.3%) |
HIV Risk |
|
Heterosexual sex | 99 (72.7%) |
IVDU/Blood and Blood Products | 21 (15.4%) |
Homosexual/Bisexual | 10 (7.3%) |
Occupational | 6 (4.4%) |
Religion |
|
Hindu | 109 (80.2%) |
Christian | 24 (17.6%) |
Muslim/Others | 3 (2.2%) |
Occupation of the Participant |
|
Professional/Blue Collar Job | 27 (19.9%) |
Skilled Laborer | 46 (33.8%) |
Daily Wage Laborer | 12 (8.8%) |
Housewife | 31 (22.8%) |
Others/Unemployed/Student | 20 (14.7%) |
Baseline WHO Classification Stage III or IV | 81 (59.5%) |
Baseline Presence of any OI | 45 (33.3%) |
Persons with Tuberculosis | 38 (28.2%) |
Baseline CD4 cell Count (cells/cumm) | 165.8 |
Baseline Weight (Kg) | 54.7 |
Type of ART used |
|
Nevirapine +2 nRTIs | 107 (78.7%) |
Efavirenz + 2 nRTIs | 26 (19.1%) |
Protease Inhibitors +2 nRTIs | 3 (2.2%) |
100% Adherence to ART reported in Prior Week | 128 (96.9%) |